Rodney Sinclair

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Kristian Reich, Kim Papp, Andrew Blauvelt et al. · The Lancet · 2017 · 540 citations

Tildrakizumab Versus Placebo, Resurface 1, Clinical Trials +6

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 452 citations · Full text

Allergy, Atopic Dermatitis, Medicine +9

Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity

Christos C. Zouboulis, Thrasyvoulos Tzellos, Gregor B. E. Jemec et al. · British Journal of Dermatology · 2017 · 430 citations · Full text

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 419 citations · Full text

Comparative Analysis of Paracrine Factor Expression in Human Adult Mesenchymal Stem Cells Derived from Bone Marrow, Adipose, and Dermal Tissue

Sarah Hsiao, Azar Asgari, Zerina Lokmic‐Tomkins et al. · Stem Cells and Development · 2011 · 413 citations · Full text

Adult Stem Cell, Immunology, Regenerative Medicine +21